Attached files
file | filename |
---|---|
8-K - FORM 8-K - WATERS CORP /DE/ | b86189e8vk.htm |
Exhibit 99.1
For Immediate Release
Contact: Gene Cassis, Vice President of Investor Relations, 508-482-2349
Waters Reports First Quarter 2011 Financial Results
Milford, Massachusetts, April 26, 2011 Waters Corporation (NYSE/WAT) reported first quarter 2011
sales of $428 million, an increase of 16%, from sales of $368 million in the first quarter of 2010.
In the quarter, foreign currency translation added 2% to sales growth. On a GAAP basis, earnings
per diluted share (E.P.S.) for the first quarter were $1.01, compared to $0.79 for the first
quarter of 2010. On a non-GAAP basis, including the adjustments in the attached reconciliation,
E.P.S. grew 28% to $1.04 from $0.81 in the prior year quarter.
Commenting on the Companys performance, Douglas Berthiaume, Chairman, President and Chief
Executive Officer said, Our strong performance in the quarter is indicative of broad customer
acceptance of our new system offerings, continuing expansion of our key Asian businesses and an
overall healthier spending environment in our pharmaceutical end-markets.
As communicated in a prior press release, Waters Corporation will webcast its first quarter 2011
financial results conference call this morning, April 26, 2011 at 8:30 a.m. eastern time. To
listen to the call, connect to www.waters.com, choose Investor Relations and click on the Live
Webcast. A replay will be available through May 3, 2011 at midnight eastern time, similarly by
webcast and also by phone at 203-369-0387.
About Waters Corporation
For over
50 years, Waters Corporation (NYSE/WAT) has created business advantages for
laboratory-dependent organizations by delivering practical and sustainable innovation to enable
significant advancements in such areas as healthcare delivery, environmental management, food
safety, and water quality worldwide.
Pioneering a connected portfolio of separations science, laboratory information management, mass
spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide
an enduring platform for customer success.
With revenue of $1.64 billion in 2010 and 5,400 employees, Waters is driving scientific discovery
and operational excellence for customers worldwide.
CAUTIONARY STATEMENT
This release may contain forward-looking statements regarding future results and events,
including statements regarding customer acceptance of our products,
expansion of our business in Asia and spending by certain end-markets that
involve a number of risks and uncertainties. For this purpose, any statements that are not
statements of historical fact may be deemed forward-looking statements. Without limiting the
foregoing, the words, believes, anticipates, plans, expects, intends, appears,
estimates, projects, and similar expressions are intended to identify forward-looking
statements. The Companys actual future results may differ significantly from the results
discussed in the forward-looking statements within this release for a variety of reasons, including
and without limitation, the impact on demand among the Companys various market sectors from
economic uncertainties; increased regulatory burdens as the Companys
business evolves, especially with respect to the U.S. Securities and Exchange Commission, U.S. Food
and Drug Administration, and U.S. Environmental Protection Agency, among others; shifts in taxable
income in jurisdictions with different effective tax rates; the outcome of tax examinations or
changes in respective country legislation affecting the Companys effective tax rate; the ability
to access capital in volatile market conditions; fluctuations in capital expenditures by the
Companys customers, in particular large pharmaceutical companies; the ability to sustain and
enhance service and consumable demand from the Companys installed base of instruments; regulatory
and/or administrative obstacles to the timely completion of purchase order documentation;
introduction of competing products by other companies and loss of market share; pressures on prices
from competitors and/or customers; regulatory, economic and competitive obstacles to new product
introductions; other changes in demand from the effect of mergers and acquisitions by the Companys
customers; environmental and logistical obstacles affecting the distribution of products; risks
associated with lawsuits and other legal actions, particularly involving claims for infringement of
patents and other intellectual property rights; the impact of changes in accounting principles and
practices; and foreign exchange rate fluctuations potentially affecting translation of the
Companys future non-U.S. operating results. Such factors and others are discussed more fully in
the section entitled Risk Factors of the Companys annual report on Form 10-K for the year ended
December 31, 2010 as filed with the Securities and Exchange Commission, which Risk Factors
discussion is incorporated by reference in this release. The forward-looking statements included in
this release represent the Companys estimates or views as of the date of this release report and
should not be relied upon as representing the Companys estimates or views as of any date
subsequent to the date of this release.
Waters Corporation and Subsidiaries
Condensed Consolidated Balance Sheets
(In thousands and unaudited)
Condensed Consolidated Balance Sheets
(In thousands and unaudited)
April 2, 2011 | December 31, 2010 | |||||||
Cash, cash equivalents and short-term investments |
1,039,049 | 946,419 | ||||||
Accounts receivable |
349,397 | 358,237 | ||||||
Inventories |
223,882 | 204,300 | ||||||
Other current assets |
71,006 | 77,685 | ||||||
Total current assets |
1,683,334 | 1,586,641 | ||||||
Property, plant and equipment, net |
216,989 | 215,060 | ||||||
Other assets |
546,839 | 525,969 | ||||||
Total assets |
2,447,162 | 2,327,670 | ||||||
Notes payable and debt |
390,346 | 66,055 | ||||||
Accounts payable and accrued expenses |
325,883 | 319,795 | ||||||
Total current liabilities |
716,229 | 385,850 | ||||||
Long-term debt |
400,000 | 700,000 | ||||||
Other long-term liabilities |
180,139 | 173,023 | ||||||
Total liabilities |
1,296,368 | 1,258,873 | ||||||
Total equity |
1,150,794 | 1,068,797 | ||||||
Total liabilities and equity |
2,447,162 | 2,327,670 |
Waters Corporation and Subsidiaries
Consolidated Statements of Operations
(In thousands, except per share data)
(Unaudited)
Consolidated Statements of Operations
(In thousands, except per share data)
(Unaudited)
(Unaudited) | ||||||||
Three Months Ended | ||||||||
April 2, 2011 | April 3, 2010 | |||||||
Net sales |
$ | 427,603 | $ | 367,700 | ||||
Cost of sales |
169,829 | 145,932 | ||||||
Gross profit |
257,774 | 221,768 | ||||||
Selling and administrative expenses (1) (2) |
117,124 | 106,693 | ||||||
Research and development expenses |
22,254 | 20,076 | ||||||
Purchased intangibles amortization |
2,501 | 2,642 | ||||||
Operating income |
115,895 | 92,357 | ||||||
Interest expense, net |
(3,370 | ) | (2,285 | ) | ||||
Income from operations before income taxes |
112,525 | 90,072 | ||||||
Provision for income taxes (3) |
18,036 | 14,554 | ||||||
Net income |
$ | 94,489 | $ | 75,518 | ||||
Net income per basic common share |
$ | 1.03 | $ | 0.81 | ||||
Weighted-average number of basic common shares |
91,649 | 93,629 | ||||||
Net income per diluted common share |
$ | 1.01 | $ | 0.79 | ||||
Weighted-average number of diluted common shares and equivalents |
93,313 | 95,223 |
(1) | Included in selling and administrative expenses for both the three months ended April 2, 2011 and April 3, 2010 are restructuring costs of $1 million related to cost reduction plans. | |
(2) | Included in selling and administrative expenses for the three months ended April 2, 2011 and April 3, 2010 are costs of less than $1 million and $1 million, respectively, associated with asset impairments related to certain Company facilities. | |
(3) | Included in the provision for income taxes for the three months ended April 3, 2010 is a tax benefit of $2 million related to the resolution of a pre-acquisition tax exposure. |
Waters Corporation and Subsidiaries
Consolidated Statements of Operations
(In thousands, except per share data)
(Unaudited)
Consolidated Statements of Operations
(In thousands, except per share data)
(Unaudited)
(Unaudited) | ||||||||
Three Months Ended | ||||||||
April 2, 2011 | April 3, 2010 | |||||||
Reconciliation of net income per diluted share, in accordance with
generally accepted accounting principles, with adjusted results: |
||||||||
Net income per diluted share |
$ | 1.01 | $ | 0.79 | ||||
Adjustment for purchased intangibles amortization, net of tax |
1,838 | 1,911 | ||||||
Net income per diluted share effect |
0.02 | 0.02 | ||||||
Adjustment for restructuring costs, net of tax |
369 | 524 | ||||||
Net income per diluted share effect |
0.00 | 0.01 | ||||||
Adjustment for asset impairments, net of tax |
313 | 624 | ||||||
Net income per diluted share effect |
0.00 | 0.01 | ||||||
Adjustment for one-time tax benefits |
| (1,500 | ) | |||||
Net income per diluted share effect |
| (0.02 | ) | |||||
Adjusted net income per diluted share |
$ | 1.04 | $ | 0.81 | ||||
The adjusted net income per diluted share presented above is used by the management of the Company
to measure operating performance with prior periods and is not in accordance with generally
accepted accounting principles (GAAP). The above reconciliation identifies items management has
excluded as non-operational transactions, net of the effective applicable statutory tax rates.
Management has excluded the purchased intangibles amortization, restructuring costs, asset
impairments and one-time tax benefits from its non-GAAP adjusted amounts since management believes
that these items are not directly related to ongoing operations, thereby providing management and
investors with information that may help them to compare ongoing operating performance.